Paragon 28 is a medical device company focused on the foot and ankle orthopedic market. Co.'s orthopedic solutions, procedural approaches and instrumentation cover a range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity, charcot foot and orthobiologics. Co. provides a portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation, including plates, screws, staples, nails, joint and bone replacements, and orthobiologics. Co.'s plating systems: Gorilla Plating System, Baby Gorilla Plating System and Silverback Ankle Fusion Plating System. We show 6 historical shares outstanding datapoints in our coverage of FNA's shares outstanding history.
Understanding the changing numbers of FNA shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like FNA versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching FNA by allowing them to research FNA shares outstanding history
as well as any other stock in our coverage universe. |
Free FNA Email Alerts:
Video: Shares Outstanding Importance
